Cibc Asset Management Inc Deciphera Pharmaceuticals, Inc. Transaction History

Cibc Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$7.7 - $37.13 $4.21 Million - $20.3 Million	-547,084 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$26.46 - $37.15 $6,853 - $9,621	259 Added 0.05%	547,084 $18.6 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $17.9 Million - $26.2 Million	546,825 New	546,825 $20 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $2.48 Million - $5.48 Million	-78,371 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$19.95 - $38.85 $254,781 - $496,153	-12,771 Reduced 14.01%	78,371 $2.66 Million
Q2 2019 Aug 05, 2019	BUY	$21.05 - $26.21 $1.05 Million - $1.31 Million	49,884 Added 120.91%	91,142 $2.06 Million
Q1 2019 May 06, 2019	BUY	$20.65 - $29.55 $851,977 - $1.22 Million	41,258 New	41,258 $958,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.